Immunome, Inc.
665 Stockton Drive, Suite 300
Exton, PA 19341
November 22, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Tamika N. Sheppard
Re: | Immunome, Inc. |
Registration Statement on Form S-3
File No. 333-275598
Acceleration Request
Requested Date: | November 27, 2023 |
Requested Time: | 4:00 PM Eastern Time |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Immunome, Inc. hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-275598) (the “Registration Statement”) to become effective on November 27, 2023, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.
Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez at Cooley LLP at (858) 550-6157 or Dylan Kornbluth of Cooley LLP at (858) 550-6173. Thank you for your assistance with this matter.
Very truly yours, | ||
Immunome, Inc. | ||
By: | /s/ Sandra Stoneman | |
Sandra Stoneman | ||
Chief Legal Officer |
cc: | Thomas Coll, Cooley LLP |
Carlos Ramirez, Cooley LLP
Dylan Kornbluth, Cooley LLP